Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Moertel

Showing results (61-70 of 251) with videos related to

Pageof 26
Sort By:
Cancer Treatment Reports|June 1, 1976
Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancerH O Douglass, P T Lavin, C G Moertel
Cancer Treatment Reports|June 1, 1983
Treatment of metastatic carcinoid tumor with dactinomycin or dacarbazineG A van Hazel, J Rubin, C G Moertel
JAMA|March 13, 1978
Carcinoembryonic antigen test for recurrent colorectal carcinoma. Inadequacy for early detectionC G Moertel, A J Schutt, V L Go
Annals of Internal Medicine|May 1, 1974
Mesenteric lipodystrophyR E Kipfer, C G Moertel, D C Dahlin
Cancer Treatment Reports|July 1, 1982
Phase II trial of doxorubicin therapy for advanced islet cell carcinomaC G Moertel, P T Lavin, R G Hahn
The New England Journal of Medicine|October 28, 1993
Screening for colorectal cancerD A Ahlquist, C G Moertel, D B McGill
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1970
Surgical management of multiple polyposis. The problem of cancer in the retained bowel segmentC G Moertel, J R Hill, M A Adson
Surgery, Gynecology & Obstetrics|February 1, 1970
Oral methotrexate therapy of gastrointestinal carcinomaC G Moertel, R J Reitemeier, R G Hahn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
What is the value of methotrexate in the treatment of advanced colorectal cancer?M J O'Connell, C G Moertel, M A Poon
Cancer Chemotherapy Reports|April 1, 1972
Effect of concomitant drug treatment on toxic and therapeutic activity of 5-fluorouracil (5-FU; NSC-19893)C G Moertel, R J Reitemeier, R G Hahn
Pageof 26

Showing results (61-70 of 251) with videos related to

Sort By:
Pageof 26
Cancer Treatment Reports|June 1, 1976
Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancerH O Douglass, P T Lavin, C G Moertel
Cancer Treatment Reports|June 1, 1983
Treatment of metastatic carcinoid tumor with dactinomycin or dacarbazineG A van Hazel, J Rubin, C G Moertel
JAMA|March 13, 1978
Carcinoembryonic antigen test for recurrent colorectal carcinoma. Inadequacy for early detectionC G Moertel, A J Schutt, V L Go
Annals of Internal Medicine|May 1, 1974
Mesenteric lipodystrophyR E Kipfer, C G Moertel, D C Dahlin
Cancer Treatment Reports|July 1, 1982
Phase II trial of doxorubicin therapy for advanced islet cell carcinomaC G Moertel, P T Lavin, R G Hahn
The New England Journal of Medicine|October 28, 1993
Screening for colorectal cancerD A Ahlquist, C G Moertel, D B McGill
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1970
Surgical management of multiple polyposis. The problem of cancer in the retained bowel segmentC G Moertel, J R Hill, M A Adson
Surgery, Gynecology & Obstetrics|February 1, 1970
Oral methotrexate therapy of gastrointestinal carcinomaC G Moertel, R J Reitemeier, R G Hahn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
What is the value of methotrexate in the treatment of advanced colorectal cancer?M J O'Connell, C G Moertel, M A Poon
Cancer Chemotherapy Reports|April 1, 1972
Effect of concomitant drug treatment on toxic and therapeutic activity of 5-fluorouracil (5-FU; NSC-19893)C G Moertel, R J Reitemeier, R G Hahn
Pageof 26